LGL Partners LLC Buys Shares of 14,500 Liquidia Corporation $LQDA

LGL Partners LLC bought a new stake in shares of Liquidia Corporation (NASDAQ:LQDA) during the 4th quarter, Holdings Channel.com reports. The fund bought 14,500 shares of the company’s stock, valued at approximately $500,000.

Several other hedge funds and other institutional investors have also bought and sold shares of the stock. PSP Research LLC bought a new stake in Liquidia during the 4th quarter valued at $534,000. Covestor Ltd raised its stake in shares of Liquidia by 41.9% during the 4th quarter. Covestor Ltd now owns 1,216 shares of the company’s stock worth $42,000 after acquiring an additional 359 shares in the last quarter. PNC Financial Services Group Inc. raised its stake in shares of Liquidia by 7.2% during the 4th quarter. PNC Financial Services Group Inc. now owns 6,304 shares of the company’s stock worth $217,000 after acquiring an additional 422 shares in the last quarter. GSA Capital Partners LLP lifted its position in Liquidia by 63.6% during the fourth quarter. GSA Capital Partners LLP now owns 63,176 shares of the company’s stock valued at $2,179,000 after acquiring an additional 24,555 shares during the last quarter. Finally, ProShare Advisors LLC lifted its position in Liquidia by 7.1% during the fourth quarter. ProShare Advisors LLC now owns 11,756 shares of the company’s stock valued at $405,000 after acquiring an additional 775 shares during the last quarter. Institutional investors own 64.54% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on LQDA shares. Oppenheimer increased their target price on shares of Liquidia from $16.00 to $19.00 and gave the company an “underperform” rating in a research report on Thursday, March 12th. Zacks Research raised shares of Liquidia from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, May 5th. HC Wainwright increased their price objective on Liquidia from $55.00 to $67.00 and gave the company a “buy” rating in a report on Tuesday, May 12th. BTIG Research increased their price objective on Liquidia from $50.00 to $59.00 and gave the company a “buy” rating in a report on Monday, May 11th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Liquidia in a report on Tuesday, April 21st. Three analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Liquidia has a consensus rating of “Moderate Buy” and an average price target of $49.33.

Liquidia Stock Performance

Shares of LQDA opened at $60.98 on Tuesday. Liquidia Corporation has a 12 month low of $11.85 and a 12 month high of $62.30. The stock has a fifty day moving average price of $42.53 and a 200-day moving average price of $37.56. The company has a current ratio of 2.22, a quick ratio of 2.03 and a debt-to-equity ratio of 1.18. The firm has a market cap of $5.42 billion, a PE ratio of 435.60 and a beta of 0.41.

Liquidia (NASDAQ:LQDA) last issued its quarterly earnings data on Monday, May 11th. The company reported $0.52 EPS for the quarter, beating the consensus estimate of $0.41 by $0.11. Liquidia had a return on equity of 46.82% and a net margin of 7.74%.The firm had revenue of $132.87 million during the quarter, compared to analyst estimates of $119.44 million. The company’s quarterly revenue was up 4187.1% on a year-over-year basis. Equities research analysts predict that Liquidia Corporation will post 2.97 earnings per share for the current fiscal year.

Insider Activity

In other Liquidia news, Director Caligan Partners Lp acquired 5,300 shares of the firm’s stock in a transaction dated Tuesday, May 19th. The stock was purchased at an average price of $59.98 per share, for a total transaction of $317,894.00. Following the acquisition, the director owned 8,138,951 shares in the company, valued at approximately $488,174,280.98. This trade represents a 0.07% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Stephen M. Bloch sold 318,893 shares of the firm’s stock in a transaction on Monday, May 11th. The stock was sold at an average price of $50.23, for a total value of $16,017,995.39. Following the completion of the transaction, the director owned 1,870,042 shares of the company’s stock, valued at $93,932,209.66. This trade represents a 14.57% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 1,047,713 shares of company stock worth $46,156,003. Company insiders own 25.60% of the company’s stock.

Liquidia Company Profile

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).